SCHEMBL31069733

SCHEMBL31069733

Nc1nc2cc(-c3cnc4c(c3)C(=O)N(Cc3cc(OC(F)(F)F)ccc3F)CCO4)ccn2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 10/20 0.48
SCN1A P35498 1/20 0.45
SCN4A P35499 1/20 0.45
KCNH2 Q12809 1/20 0.45
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
SCN2A Q99250 1/20 0.45
SCN3A Q9NY46 1/20 0.45
SCN8A Q9UQD0 1/20 0.45
SCN10A Q9Y5Y9 1/20 0.45
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
ALPL P05186 2/20 0.37
PIK3CG P48736 4/20 0.36
PIK3CD O00329 3/20 0.36
DGAT1 O75907 2/20 0.36
AURKA O14965 1/20 0.33
FLT1 P17948 1/20 0.33
GCK P35557 1/20 0.33
FLT4 P35916 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25379735 1.00 TNIK (0.48) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25416521 0.90 TNIK (0.54) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069728 0.89 SCN1A (0.43) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL23761157 0.88 TNIK (0.41) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380573 0.88 TNIK (0.47) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069717 0.88 TNIK (0.47) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25378533 0.88 TNIK (0.46) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25379054 0.87 SCN1A (0.42) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380390 0.87 TNIK (0.41) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380728 0.87 TNIK (0.40) TNIKSCN1ASCN4AKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556044-A Fused heterocyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-27 CN disclosed